Citius Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $3,944 | $0 | $0 | $0 |
Gross Profit | 2,581 | -62 | -41 | -56 |
EBITDA | -8,445 | -8,321 | -8,726 | -11,191 |
EBIT | -9,019 | -8,383 | -8,767 | -11,247 |
Net Income | -8,220 | -7,959 | -8,789 | -10,916 |
Net Change In Cash | 3,944 | 0 | 0 | 0 |
Free Cash Flow | -13,008 | -11,880 | -5,406 | -4,539 |
Cash | 7,721 | 4,252 | 6,089 | 26 |
Basic Shares | 21,495 | 18,067 | 11,006 | 11,590 |
Annual Financials
| Values in thousands | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -214 | -209 | -194 | -179 |
EBITDA | -38,201 | -38,640 | -31,772 | -32,884 |
EBIT | -38,415 | -38,849 | -31,966 | -33,064 |
Net Income | -37,433 | -39,138 | -32,542 | -33,640 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -28,361 | |||
Free Cash Flow | -26,552 | -28,201 | -29,060 | -28,361 |
Cash | 4,252 | 3,251 | 26,480 | 41,711 |
Basic Shares | 11,065 | 11,590 | 10,086 | 9,738 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$0.38 |
2025-09-30 | -$0.46 |
2025-06-30 | -$0.80 |
2025-03-31 | -$1.27 |
